Evaluation of the Cancer Tracking System (CATSystem)

NCT ID: NCT06286462

Last Updated: 2025-04-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

6600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-05

Study Completion Date

2028-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cervical cancer contributes to significant preventable mortality in Kenya where less than 20% of women are screened. The Cancer Tracking System (CATSystem) is a web-based, algorithm generated tool to promote guideline adherent cervical cancer screening and retention through treatment. The goal of this project is to rigorously evaluate the efficacy, implementation, and cost-effectiveness of the CATSystem to improve rates of screening, treatment, referral, and follow-up care in a matched, cluster randomized controlled trial in 10 Kenyan government hospitals (5 intervention, 5 standard of care).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To help address system level barriers to cervical cancer screening, treatment, and follow-up in Kenya, investigators worked with end-users (providers and patients) to develop the Cancer Tracking System (CATSystem), a web-based, algorithm generated tool to promote guideline adherent cervical cancer screening and retention through treatment. The goal of this project is to rigorously evaluate the efficacy, implementation, and cost-effectiveness of the CATSystem to improve rates of screening, treatment, referral, and follow-up care in a matched, cluster randomized controlled trial in 10 Kenyan government hospitals (5 intervention, 5 standard of care). Specific aims (SA) of the study are to (1) Implement and evaluate the efficacy of CATSystem to improve guideline adherent cervical cancer screening, treatment, referral and follow up, (2) Assess feasibility and acceptability of implementation of CATSystem in government run facilities using a human centered design approach, and (3) Calculate the costs and cost-effectiveness of the CATSystem to increase quality adjusted life years gained. Cervical cancer deaths can be prevented with early detection and treatment. This study will evaluate the public health impact of the CATSystem in improving cervical cancer screening, treatment, referral, follow-up, and the feasibility of scale up to other low resource settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Matched, cluster randomized controlled design
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CATSystem Intervention

Participants enrolled at intervention sites will receive CATSytem-supported cervical cancer screening and treatment services. Interventions received will include: text messages to patients and algorithm-driven alerts to providers when guideline-adherent cervical cancer screening and treatment services are required including: initial and follow up cervical cancer screening, on site treatment, and referral tracking.

Group Type EXPERIMENTAL

Cancer Tracking System (CATSystem)

Intervention Type OTHER

The CATSystem provider dashboard highlights patients with overdue services or those in need of outreach and sends automated, customized texts to support screening and treatment follow-up per national guidelines. Points of intervention and alerts include: cervical cancer screening and treatment counseling, initial and follow up cervical cancer screening per national guidelines, treatment for precancer and cancer, referral tracking and follow up. In addition, the CATSystem can securely store images of the cervix taken with colposcopes to allow for remote expert consultation if needed to correctly diagnose a patient or can be reviewed at clinical team meetings for input. Primary goals of the CATSystem are to increase rates of guideline-adherent cervical cancer screening/ rescreening and improve guideline-adherent treatment, referral, and follow-up rates of women with positive screens.

Standard of care

Participants enrolled at control sites will receive standard of care PMTCT services, with no CATSystem tracking or follow up

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cancer Tracking System (CATSystem)

The CATSystem provider dashboard highlights patients with overdue services or those in need of outreach and sends automated, customized texts to support screening and treatment follow-up per national guidelines. Points of intervention and alerts include: cervical cancer screening and treatment counseling, initial and follow up cervical cancer screening per national guidelines, treatment for precancer and cancer, referral tracking and follow up. In addition, the CATSystem can securely store images of the cervix taken with colposcopes to allow for remote expert consultation if needed to correctly diagnose a patient or can be reviewed at clinical team meetings for input. Primary goals of the CATSystem are to increase rates of guideline-adherent cervical cancer screening/ rescreening and improve guideline-adherent treatment, referral, and follow-up rates of women with positive screens.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women above 16 years of age
* access to a cell phone,
* presenting for cervical cancer screening at a study hospital.

Exclusion Criteria

* greater than 20 weeks gestation,
* incarcerated patients,
* women who study staff feel are unable to provide written informed consent due to impaired capacity.
Minimum Eligible Age

16 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Global Health Innovations

OTHER

Sponsor Role collaborator

DARTNet Institute

OTHER_GOV

Sponsor Role collaborator

San Diego State University

OTHER

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role collaborator

University of Kansas Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sarah Finocchario-Kessler, PhD

Role: PRINCIPAL_INVESTIGATOR

Univer

Natabhona Mabachi, PhD

Role: PRINCIPAL_INVESTIGATOR

DARTNet Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Akala Health Center

Akala, , Kenya

Site Status RECRUITING

Bondo Referral Hospital

Bondo, , Kenya

Site Status RECRUITING

Alupe Sub-County Hospital

Busia, , Kenya

Site Status RECRUITING

Busia County Referral Hospital

Busia, , Kenya

Site Status RECRUITING

Khunyangu Sub-County Hospital

Busia, , Kenya

Site Status RECRUITING

Matayos Health Center

Busia, , Kenya

Site Status RECRUITING

Port Victoria Sub-County Hospital

Busia, , Kenya

Site Status RECRUITING

Nambale Sub-County Hospital

Siaya, , Kenya

Site Status RECRUITING

Yala Sub-County Hospital

Siaya, , Kenya

Site Status RECRUITING

Ukwala Sub-County Hospital

Ukwala, , Kenya

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Kenya

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Catherine Wexler, MPH

Role: CONTACT

913-945-7077

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

May H Maloba, MCH

Role: primary

+254720254069

John Ochieng, BA

Role: backup

+254735870242

May H Maloba, MCH

Role: primary

+254720254069

John Ochieng, BA

Role: backup

+254735870242

May H Maloba

Role: primary

+254720254069

John Ochieng

Role: backup

+254735870242

May H Maloba, MCH

Role: primary

+254720254069

John Ochieng, BA

Role: backup

+254735870242

May H Maloba

Role: primary

+254720254069

John Ochieng

Role: backup

+254735870242

May H Maloba

Role: primary

+254720254069

John Ochieng

Role: backup

+254735870242

May H Maloba, MCH

Role: primary

+254720254069

John Ochieng, BA

Role: backup

+254735870242

May H Maloba

Role: primary

+254720254069

John Ochieng

Role: backup

+254735870242

May H Maloba

Role: primary

+254720254069

John Ochieng

Role: backup

+254735870242

May H Maloba

Role: primary

+254720254069

John Ochieng

Role: backup

+254735870242

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01CA278617

Identifier Type: NIH

Identifier Source: org_study_id

View Link

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Cervical Cancer Prevention Program in Kenya
NCT06411938 ACTIVE_NOT_RECRUITING NA